208 related articles for article (PubMed ID: 22027369)
1. Monitored whole gene in vitro evolution of an anti-hRaf-1 affibody molecule towards increased binding affinity.
Grimm S; Salahshour S; Nygren PÅ
N Biotechnol; 2012 Jun; 29(5):534-42. PubMed ID: 22027369
[TBL] [Abstract][Full Text] [Related]
2. Selection and characterization of Affibody ligands to the transcription factor c-Jun.
Lundberg E; Brismar H; Gräslund T
Biotechnol Appl Biochem; 2009 Jan; 52(Pt 1):17-27. PubMed ID: 18260830
[TBL] [Abstract][Full Text] [Related]
3. Selection and characterisation of affibody molecules inhibiting the interaction between Ras and Raf in vitro.
Grimm S; Lundberg E; Yu F; Shibasaki S; Vernet E; Skogs M; Nygren PÅ; Gräslund T
N Biotechnol; 2010 Dec; 27(6):766-73. PubMed ID: 20674812
[TBL] [Abstract][Full Text] [Related]
4. Design of an optimized scaffold for affibody molecules.
Feldwisch J; Tolmachev V; Lendel C; Herne N; Sjöberg A; Larsson B; Rosik D; Lindqvist E; Fant G; Höidén-Guthenberg I; Galli J; Jonasson P; Abrahmsén L
J Mol Biol; 2010 Apr; 398(2):232-47. PubMed ID: 20226194
[TBL] [Abstract][Full Text] [Related]
5. Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand.
Wållberg H; Löfdahl PK; Tschapalda K; Uhlén M; Tolmachev V; Nygren PK; Ståhl S
Protein Expr Purif; 2011 Mar; 76(1):127-35. PubMed ID: 21029777
[TBL] [Abstract][Full Text] [Related]
6. Selection of TNF-alpha binding affibody molecules using a beta-lactamase protein fragment complementation assay.
Löfdahl PA; Nord O; Janzon L; Nygren PA
N Biotechnol; 2009 Nov; 26(5):251-9. PubMed ID: 19576305
[TBL] [Abstract][Full Text] [Related]
7. Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro.
Jonsson A; Wållberg H; Herne N; Ståhl S; Frejd FY
Biotechnol Appl Biochem; 2009 Aug; 54(2):93-103. PubMed ID: 19545237
[TBL] [Abstract][Full Text] [Related]
8. Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides.
Grönwall C; Jonsson A; Lindström S; Gunneriusson E; Ståhl S; Herne N
J Biotechnol; 2007 Jan; 128(1):162-83. PubMed ID: 17088007
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotypic protein domains selected from protein A-based affibody libraries.
Eklund M; Axelsson L; Uhlén M; Nygren PA
Proteins; 2002 Aug; 48(3):454-62. PubMed ID: 12112671
[TBL] [Abstract][Full Text] [Related]
10. A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry.
Kronqvist N; Löfblom J; Jonsson A; Wernérus H; Ståhl S
Protein Eng Des Sel; 2008 Apr; 21(4):247-55. PubMed ID: 18239074
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for molecular recognition in an affibody:affibody complex.
Lendel C; Dogan J; Härd T
J Mol Biol; 2006 Jun; 359(5):1293-304. PubMed ID: 16750222
[TBL] [Abstract][Full Text] [Related]
12. Selection and characterization of an HIV-1 gp120-binding affibody ligand.
Wikman M; Rowcliffe E; Friedman M; Henning P; Lindholm L; Olofsson S; Ståhl S
Biotechnol Appl Biochem; 2006 Sep; 45(Pt 2):93-105. PubMed ID: 16712522
[TBL] [Abstract][Full Text] [Related]
13. High-affinity binding to staphylococcal protein A by an engineered dimeric Affibody molecule.
Lindborg M; Dubnovitsky A; Olesen K; Björkman T; Abrahmsén L; Feldwisch J; Härd T
Protein Eng Des Sel; 2013 Oct; 26(10):635-44. PubMed ID: 23924760
[TBL] [Abstract][Full Text] [Related]
14. Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule.
Friedman M; Orlova A; Johansson E; Eriksson TL; Höidén-Guthenberg I; Tolmachev V; Nilsson FY; Ståhl S
J Mol Biol; 2008 Mar; 376(5):1388-402. PubMed ID: 18207161
[TBL] [Abstract][Full Text] [Related]
15. Engineering of a femtomolar affinity binding protein to human serum albumin.
Jonsson A; Dogan J; Herne N; Abrahmsén L; Nygren PA
Protein Eng Des Sel; 2008 Aug; 21(8):515-27. PubMed ID: 18499681
[TBL] [Abstract][Full Text] [Related]
16. Affinity maturation of a TNFalpha-binding affibody molecule by Darwinian survival selection.
Löfdahl PA; Nygren PA
Biotechnol Appl Biochem; 2010 Mar; 55(3):111-20. PubMed ID: 20121700
[TBL] [Abstract][Full Text] [Related]
17. Thermodynamics of folding and binding in an affibody:affibody complex.
Dogan J; Lendel C; Härd T
J Mol Biol; 2006 Jun; 359(5):1305-15. PubMed ID: 16701696
[TBL] [Abstract][Full Text] [Related]
18. RNA mutagenesis yields highly diverse mRNA libraries for in vitro protein evolution.
Kopsidas G; Carman RK; Stutt EL; Raicevic A; Roberts AS; Siomos MA; Dobric N; Pontes-Braz L; Coia G
BMC Biotechnol; 2007 Apr; 7():18. PubMed ID: 17425805
[TBL] [Abstract][Full Text] [Related]
19. Affinity maturation of human growth hormone by monovalent phage display.
Lowman HB; Wells JA
J Mol Biol; 1993 Dec; 234(3):564-78. PubMed ID: 8254660
[TBL] [Abstract][Full Text] [Related]
20. Engineered high-affinity affibody molecules targeting platelet-derived growth factor receptor β in vivo.
Lindborg M; Cortez E; Höidén-Guthenberg I; Gunneriusson E; von Hage E; Syud F; Morrison M; Abrahmsén L; Herne N; Pietras K; Frejd FY
J Mol Biol; 2011 Mar; 407(2):298-315. PubMed ID: 21277312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
